ATX- given results of pre-clinical work will be released in this quarter. Traders will be all over this, Low SOI, and is highly likely that results are positive. Biotechs can go crazy!
I must say, they are targeting a billion dollar market, have a novel approach IMHO is undervalued COMPARED to other biotechs. market cap is a joke, expecting a significant rerate here with time for long term suffering shareholders .they just received FDA designation for their drug yesterday at about 3pm. Expecting it go gap up today as it hit 24c yesterday!
